Refractory Acute Myeloid Leukemia
specificAn acute myeloid leukemia that does not respond to treatment.
39
Centers
95
Active Trials
$2M
Cancer Funding
Top Centers for Refractory Acute Myeloid Leukemia(39)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive High-Volume Research Center | 82.2 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 72.2 |
| 3 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 72.2 |
| 4 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 69.9 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 69.9 |
| 6 | NCI Clinical Active Research Program | 67.6 |
| 7 | University of Illinois Cancer CenterChicago, IL Active Research Program | 67.6 |
| 8 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 64.7 |
| 9 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 64.7 |
| 10 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 60.1 |
| 11 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 60.1 |
| 12 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 60.1 |
| 13 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 60.1 |
| 14 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 60.1 |
| 15 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 52.6 |
| 16 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 52.6 |
| 17 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 52.6 |
| 18 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive Active Research Program | 52.6 |
| 19 | NCI Comprehensive Active Research Program | 52.6 |
| 20 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 52.6 |
| 21 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 52.6 |
| 22 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 52.6 |
| 23 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 38.7 |
| 24 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 38.7 |
| 25 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 38.7 |
| 26 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 38.7 |
| 27 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 38.7 |
| 28 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 38.7 |
| 29 | NCI Comprehensive Active Research Program | 38.7 |
| 30 | NCI Comprehensive Active Research Program | 38.7 |
| 31 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 38.7 |
| 32 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 38.7 |
| 33 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 38.7 |
| 34 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 38.7 |
| 35 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 38.7 |
| 36 | Cancer Center at IllinoisUrbana, IL Active Research Program | 38.7 |
| 37 | Upstate Cancer CenterSyracuse, NY Active Research Program | 38.7 |
| 38 | Active Research Program | 38.7 |
| 39 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive | 28.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →